These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38310181)

  • 21. Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi-institutional retrospective analysis.
    Park SY; Park JS; Kim HJ; Kim JG; Kang BW; Baek JH; Kim HR; Kim CH; Kim YJ; Choi GS
    J Surg Oncol; 2023 Mar; 127(4):668-677. PubMed ID: 36515216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
    Ljunggren M; Nordenvall C; Palmer G
    Eur J Surg Oncol; 2021 Nov; 47(11):2865-2872. PubMed ID: 34116900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients diagnosed with colorectal peritoneal metastasis who underwent palliative chemotherapy?
    Cho HJ; Kim JW; Kim WR
    Asian J Surg; 2024 Jan; 47(1):296-302. PubMed ID: 37648541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies.
    Flood M; Narasimhan V; Waters P; Ramsay R; Michael M; Warrier S; Heriot A
    Surgeon; 2021 Oct; 19(5):310-320. PubMed ID: 33023847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definition and Prediction of Early Recurrence and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: Towards Predicting Oncologic Futility Preoperatively.
    Rieser CJ; Jones H; Hall LB; Kang E; Altpeter S; Zureikat AH; Holtzman MP; Lee A; Ongchin M; Pingpank JF; Choudry MHA; Bartlett DL
    Ann Surg Oncol; 2021 Dec; 28(13):9116-9125. PubMed ID: 34224045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?
    Gelli M; Huguenin JFL; de Baere T; Benhaim L; Mariani A; Boige V; Malka D; Sourouille I; Ducreux M; Elias D; Goéré D
    Eur J Cancer; 2018 Sep; 100():94-103. PubMed ID: 30014885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
    Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Santullo F; Vaira M; Di Lauro K; D'Acapito F; Carboni F; Milone E; Donini A; Fugazzola P; Faviana P; Sorrentino L; Pizzolato E; Cenzi C; Del Bianco P; Sommariva A
    Ann Surg Oncol; 2024 Jan; 31(1):594-604. PubMed ID: 37831280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups.
    Gomes David M; Bakrin N; Salleron J; Kaminsky MC; Bereder JM; Tuech JJ; Lehmann K; Mehta S; Glehen O; Marchal F
    BMC Surg; 2022 Jan; 22(1):1. PubMed ID: 34996419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
    Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM
    Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
    Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Baratti D; Kusamura S; Azmi N; Guaglio M; Montenovo M; Deraco M
    Ann Surg Oncol; 2020 Jan; 27(1):98-106. PubMed ID: 31691116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer.
    Engbersen MP; Aalbers AGJ; Van't Sant-Jansen I; Velsing JDR; Lambregts DMJ; Beets-Tan RGH; Kok NFM; Lahaye MJ
    Ann Surg Oncol; 2020 Sep; 27(9):3516-3524. PubMed ID: 32239338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures.
    Noiret B; Lenne X; Bruandet A; Piessen G; Eveno C
    Ann Surg Oncol; 2024 Sep; 31(9):6220-6227. PubMed ID: 38549002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study.
    Dietz MV; Ziekman MJ; van Kooten JP; Brandt-Kerkhof ARM; van Meerten E; Verhoef C; Madsen EVE
    Ann Surg Oncol; 2023 Apr; 30(4):2048-2056. PubMed ID: 36566258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry.
    Kelly ME; O'Sullivan NJ; Bolger JC; Polignano F; Youssef H; Renehan A; Malcomson L; Alves S; Cecil T; Mulsow J; Moran B; Mohamed F;
    Br J Cancer; 2023 Jan; 128(1):42-47. PubMed ID: 36347966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Boot H; van Leerdam ME; Hauptmann M; Aalbers AG; Verwaal VJ
    Ann Oncol; 2014 Apr; 25(4):864-869. PubMed ID: 24667719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin.
    Benvenisti H; Shiber M; Assaf D; Shovman Y; Laks S; Elbaz N; Mor E; Zippel D; Nissan A; Ben-Yaacov A; Adileh M
    J Gastrointest Surg; 2023 Nov; 27(11):2506-2514. PubMed ID: 37726508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study.
    Turner KM; Morris MC; Delman AM; Hanseman D; Johnston FM; Greer J; Walle KV; Abbott DE; Raoof M; Grotz TE; Fournier K; Dineen S; Veerapong J; Maduekwe U; Kothari A; Staley CA; Maithel SK; Lambert LA; Kim AC; Cloyd JM; Wilson GC; Sussman JJ; Ahmad SA; Patel SH
    J Gastrointest Surg; 2022 Dec; 26(12):2569-2578. PubMed ID: 36258061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal peritoneal metastases: analysis of short- and long-term outcomes.
    Rosa F; Galiandro F; Ricci R; Di Miceli D; Quero G; Fiorillo C; Cina C; Alfieri S
    Langenbecks Arch Surg; 2021 Dec; 406(8):2797-2805. PubMed ID: 34661754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.